Researchers from CU-Boulder will conduct cell biology experiments in microgravity, mimicking normal functioning kidney cells and studying molecular responses to infections. Plant growth experiments will also explore the role of gravity on plant development, with potential applications in timber and pharmaceutical industries.
University of Pittsburgh researchers have developed a urinary catheter that can directly measure blood flow and oxygen utilization in the body. This innovation allows for more timely monitoring of trauma patients and could lead to better outcomes by providing insights into mechanisms of organ failure.
Researchers identified Kir6.2 as a protective mechanism against stress in the heart, which helps maintain equilibrium under peak workloads. The study found that mice lacking this protein experienced severe cardiac distress and died, while those with it survived stress tests.
Researchers will use computational biolinguistics to analyze protein sequences and understand their structure, dynamics, and function. This project aims to extract information from gene sequences that may lead to developing drugs to fight degenerative diseases.
A recent survey of over 100 academic medical centers found that anesthesiology faculty members and residents have substance abuse rates of 1% and 1.6%, respectively, during their personal time. The most commonly abused medication is fentanyl, often discovered through overdose or by tracking dispensed drugs.
A phase II study of 100 patients with previously untreated HIV found that kaletra held the virus at undetectable levels for four years, with 72% maintaining suppressed viral loads. The results suggest that Kaletra remains a crucial option for initial therapy, helping to prolong time to resistance development.
Experts will share insights on developing and marketing natural medicinal products for economic feasibility and public health. The summit aims to draft a consensus statement on the safety and effectiveness of these products, which have gained popularity with numerous claims but lack research support.
The initiative involves over 50 investigators in Seattle and Vancouver, B.C., aiming to develop improved therapies for men with recurrent or advanced disease. Prostate cancer affects one in six men, with an estimated 189,000 diagnoses this year and 30,200 deaths.
Research found that reducing blood pressure to less than the standard goal also lowered artery stiffness in patients with high blood pressure. The study involved 142 nondiabetic patients who received antihypertensive drugs, resulting in a significant decrease in artery stiffness for those with lower target pressures.
Researchers at Mayo Clinic developed a new calculator to determine baseline prognosis and treatment benefits for patients with resected melanoma. The tool calculates patient potential living with no recurring cancer or after surgery and interferon therapy, empowering informed treatment decisions.
A new agreement between NIDA and SAMHSA will facilitate the dissemination of research findings from NIDA's treatment research to practitioners across the US, enhancing treatment practices. The initiative aims to reduce the time between discovering an effective treatment and its adoption in community-based care.
Researchers found that 43% of participants with mild cognitive impairment had psychiatric symptoms, and 75% of those with dementia did. The study highlights the importance of recognizing and treating these symptoms to improve patient outcomes.
Researchers at the Mayo Clinic document a safer treatment approach for atrial fibrillation, utilizing adequate anticoagulation medication to reduce the risk of stroke and thromboembolism. The study, conducted from 1990-1994, involved 834 successful cardioversions performed in 717 patients, with an incidence rate of less than 1%.